Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins

Journal of Clinical Lipidology

Volumn 4, Issue 1, 2010, Pages 59-68

  Lerman, Robert H ^a   Minich, Deanna M ^a   Darland, Gary ^a   Lamb, Joseph J ^a   Chang, Jyh Lurn ^a   Hsi, Alex ^a   Bland, Jeffrey S ^a   Tripp, Matthew L ^a  

^a MetaProteomics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUTRACEUTICAL; PHYTOSTEROL; PROANTHOCYANIDIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ACACIA; ACACIA NILOTICA; ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLYCEMIC LOAD; HUMAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MALE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PARTICLE SIZE; PRIORITY JOURNAL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ACACIA; ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HUMULUS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOSTEROLS; PHYTOTHERAPY; PROANTHOCYANIDINS; RISK FACTORS; SOYBEAN PROTEINS;

ACACIA; ACACIA NILOTICA; HUMULUS;

EID: 75749105470     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.11.002     Document Type: Article

References (21)

1. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
2. Reisin E., and Alpert M.A. Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci 330 (2005) 269-272
3. Jeppesen J., Hansen T.W., Rasmussen S., Ibsen H., and Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study. Atherosclerosis 189 (2006) 369-374
4. Campbell C.Y., Nasir K., Sarwar A., et al. Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia. Am J Cardiol 100 (2007) 840-843
5. Montalcini T., Gorgone G., Federico D., et al. Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome. Nutr Metab Cardiovasc Dis 15 (2005) 368-372
6. Kawamoto R., Tomita H., Oka Y., Kodama A., and Kamitani A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med 44 (2005) 1232-1238
7. Giugliano D., and Esposito K. Mediterranean diet and metabolic diseases. Curr Opin Lipidol 19 (2008) 63-68
8. Maki K.C., Rains T.M., Kaden V.N., Raneri K.R., and Davidson M.H. Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr 85 (2007) 724-734
9. Sloth B., Krog-Mikkelsen I., Flint A., et al. No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr 80 (2004) 337-347
10. Lukaczer D., Liska D.J., Lerman R.H., et al. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 22 (2006) 104-113
11. Lerman R.H., Minich D.M., Darland G., et al. Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial. Nutr Metab (Lond) 5 (2008) 29
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
13. Jeyarajah E.J., Cromwell W.C., and Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26 (2006) 847-870
14. Shrestha S., Freake H.C., McGrane M.M., Volek J.S., and Fernandez M.L. A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake. J Nutr 137 (2007) 1165-1170
15. Plat J., and Mensink R.P. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J 16 (2002) 258-260
16. Ruiu G., Pinach S., Veglia F., et al. Phytosterol-enriched yogurt increases LDL affinity and reduces CD36 expression in polygenic hypercholesterolemia. Lipids 44 (2009) 153-160
17. Harland J.I., and Haffner T.A. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200 (2008) 13-27
18. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
19. Cromwell W.C., Otvos J.D., Keyes M.J., et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management. J Clin Lipidol 1 (2007) 583-592
20. El Harchaoui K., van der Steeg W.A., Stroes E.S., et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 49 (2007) 547-553
21. Rosenson R.S. Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities. Curr Opin Cardiol 20 (2005) 313-317